CitiFirst Self-Funding Instalment MINI on Vanguard High Yield ETF Announces $0.4065 Distribution, Lowers VHYSO2 Loan Balance

Implications of the VHYSO2 Distribution Announcement for CitiFirst Instalment Investors

On 2 July 2026, Citigroup Global Markets Australia Pty Limited, acting as issuer of the VHY CitiFirst Self-Funding Instalment MINI, confirmed the final distribution amount for VHYSO2. The unfranked distribution of AUD $0.406508 per unit has been officially declared, providing holders with clarity on the amount that will be applied to reduce their outstanding loan balance within the self-funding instalment framework.

Paul Kedwell, Warrants and Structured Products Manager at Citigroup Global Markets Australia, signed the announcement addressed to ASX Warrants. This disclosure follows the standard procedure for self-funding instalment products, where distributions from the underlying security are used to decrease the loan component rather than being paid out as cash income to warrant holders. This mechanism is a hallmark of the self-funding instalment (SFI) product category.

Application of the $0.406508 Unfranked Distribution to the VHYSO2 Loan Balance

According to section 1.1 of the Product Disclosure Statement (PDS) for VHYSO2, distributions from the underlying VHY Vanguard Australian Shares High Yield ETF are not paid directly as cash to instalment holders. Instead, these distributions reduce the outstanding loan amount carried by the investor as part of the leveraged instalment structure. This process underpins the self-funding feature of the product.

Applying the $0.406508 distribution lowers the prior loan amount of $37.6841 per VHYSO2 unit to $37.2864. This approximately $0.3977 reduction reflects the distribution amount applied to the loan, which in turn increases the equity or instalment value component held by investors, assuming other market variables remain unchanged. It is important to note the distribution is unfranked, meaning no franking credits are attached, which may affect investors’ tax situations.

Synchronization of Record and Ex-Distribution Dates Between VHYSO2 and the VHY ETF

The company update highlights that both the record date and ex-distribution date for VHYSO2 coincide exactly with those of the underlying Vanguard Australian Shares High Yield ETF (ASX:VHY). The record date is 2 July 2026, and the ex-distribution date is 1 July 2026, mirroring the VHY ETF’s distribution schedule.

This alignment is intentional. Since VHYSO2 is structured as an instalment over VHY units, the economic benefits of the underlying ETF’s distributions flow through to the instalment level. Citigroup, as issuer and holder of the VHY units securing the loan, receives the distribution from VHY and applies it to reduce the loan balance in line with the PDS. Investors holding VHYSO2 will not receive the distribution as a separate cash payment; instead, their entitlement is reflected solely by a reduction in the loan balance attached to their instalment.

Understanding the VHYSO2 Self-Funding Instalment MINI Structure

Self-Funding Instalments (SFIs) are a category of listed warrant products issued by financial institutions such as Citigroup Global Markets Australia. They provide investors with leveraged exposure to an underlying security—in this case, the VHY Vanguard Australian Shares High Yield ETF—by requiring an initial instalment payment and an outstanding loan balance secured against the underlying holding. The "self-funding" aspect refers to the mechanism whereby distributions from the underlying security are used to progressively repay the loan.

The MINI designation identifies a particular subtype within the SFI structure. As distributions reduce the loan balance over time, the Leverage ratio of the instalment adjusts, increasing the investor’s equity component relative to the total position value. SFIs are especially suited to high-yielding securities like VHY, where regular distributions can accelerate loan repayment. Investors holding or considering VHYSO2 should consult the full PDS and seek independent financial advice to understand the tax, leverage, and Market Risk factors involved.

Vanguard Australian Shares High Yield ETF as VHYSO2’s Underlying Asset

The VHYSO2 CitiFirst instalment is backed by the VHY Vanguard Australian Shares High Yield ETF, a well-established ETF managed by Vanguard Investments Australia. VHY aims to track an index of higher-yielding Australian shares, typically comprising large and mid-cap ASX-listed companies with above-average Dividend yields. Because VHY regularly distributes income to unitholders, the SFI structure built on it captures these distributions to reduce the instalment loan over time.

The high-yield nature of VHY is central to the existence of products like VHYSO2. The consistent and relatively predictable distributions from VHY enable meaningful loan balance reductions across distribution periods. Investors should be aware that the underlying ETF’s market value—and thus their instalment position’s value—remains subject to fluctuations in the Australian equity market. The loan balance reduction does not protect holders from Capital risk inherent in the underlying holdings.

Citigroup Global Markets Australia’s Role as Warrant Issuer Under AFSL 240992

Citigroup Global Markets Australia Pty Limited (ABN 64 003 114 832, AFSL 240992) serves as issuer and manager of the CitiFirst range of warrants and structured products listed on the ASX. It is responsible for issuing disclosures such as this update when distribution events occur for its listed instalment products. The company is a participant in both the ASX Group and Cboe Australia, underscoring its significant presence in the Australian listed Derivatives and structured products markets.

The announcement was signed by Paul Kedwell, Warrants and Structured Products Manager. The CitiFirst suite includes a variety of structured products such as trading warrants, turbos, MINIs, and instalments. Investors holding CitiFirst products should ensure they receive and review distribution and loan adjustment notifications, as these directly impact the economic terms of their holdings.

Impact of Loan Balance Reduction from $37.6841 to $37.2864 for VHYSO2 Investors

For current VHYSO2 holders, this announcement means the loan component per instalment unit has decreased from $37.6841 to $37.2864, a $0.3977 reduction. This loan decrease effectively raises the net asset value or equity portion of the instalment position by the same amount, assuming all else remains equal. Investors do not need to take any action; Citigroup applies the loan adjustment automatically as per the PDS terms.

Over successive distribution cycles, these loan reductions accumulate, altering the instalment’s leverage profile. As the loan balance declines, the instalment becomes less leveraged relative to the total position, increasing the holder’s equity interest in the underlying VHY units. Investors should update their records to reflect the new loan amount of $37.2864 per unit following the 2 July 2026 record date. The announcement did not provide information on VHYSO2’s current Market Price or net Tangible Asset value.

Tax Implications of the Unfranked VHYSO2 Distribution

The declared distribution for VHYSO2 is unfranked, a significant factor for Australian investors. Unfranked distributions lack franking credits—tax credits attached to dividends paid from corporate tax already paid by Australian companies. Without franking credits, investors cannot offset their income tax liability on the distribution amount. However, since the distribution is applied to reduce the loan rather than paid as cash income, its tax treatment may differ from a direct cash dividend received by a Shareholder.

Tax treatment of self-funding instalment products is complex and depends on individual circumstances, product nature, and Australian Taxation Office guidance. This announcement does not provide tax advice or commentary on tax consequences for VHYSO2 holders. Investors are strongly advised to consult their tax adviser or Accountant to understand how the loan reduction and unfranked distribution affect their specific tax position. No taxation rulings or guidance related to this distribution were disclosed.

Upcoming Distribution Cycles and Monitoring for VHYSO2 Holders

With the 2 July 2026 record date confirmed and the loan balance adjusted to $37.2864, the next key event for VHYSO2 investors will be the forthcoming distribution announcements from the VHY Vanguard Australian Shares High Yield ETF. VHY typically distributes income quarterly, so VHYSO2 holders can anticipate further loan balance reductions in subsequent quarters, subject to VHY’s distribution policy and performance.

Investors should also monitor the VHY portfolio’s overall performance and broader Australian equity market trends, as changes in the underlying ETF’s capital value will affect the total instalment position independently of the loan reduction. The immediate market impact of this announcement on VHYSO2’s share price was not apparent from public sources. Holders are encouraged to review CitiFirst product pages and the current PDS from Citigroup Global Markets Australia for the latest terms, loan balances, and disclosures relevant to VHYSO2.